In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance.

AUTOR(ES)

Watts, J L

RESUMO

The in vitro activity of premafloxacin against 673 veterinary pathogens was evaluated. Premafloxacin was equivalent to ciprofloxacin, enrofloxacin, and danofloxacin in activity against the gram-negative bacilli but was much more active (MIC for 90% of the strains tested [MIC90], 0.015 to 0.25 microg/ml) than the comparison antimicrobial agents (MIC90, 0.13 to 16.0 microg/ml) against the staphylococci, streptococci, and anaerobes tested.

Documentos Relacionados

• In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
• In Vivo Activity of HSR-903, a New Fluoroquinolone, against Respiratory Pathogens
• In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases.
• In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against Mycoplasmas
• Extended-spectrum beta-lactamases.